Expertise in
16
conditions

Dr. Rocco T. Serrao

Dermatology
5300 Far Hills Avenue, 
Dayton, OH 
Accepting New Patients
Referral may be required
Before you request
Expertise in
16
conditions
5300 Far Hills Avenue, 
Dayton, OH 

Overview

Rocco Serrao is a Dermatologist practicing medicine in Dayton, Ohio.

Dr. Serrao is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Nevus.

Dr. Serrao is board certified in American Board Of Dermatology. He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 6 clinical trials. Dr. Serrao is currently accepting new patients.

Graduate Institution

University Of Pittsburgh, 2008

Residency

Wright State Medical School, Dermatology, 2012

Specialties

Dermatology

Licenses

Dermatology in OH

Board Certifications

American Board Of Dermatology

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 25 Less Insurance Carriers -

Locations

Dermatologists of Southwest Ohio, Inc.
5300 Far Hills Avenue, Dayton, OH 45429
Other Locations
Dermatologists of Southwest Ohio, Inc.
45 South Stanfield Road, Suite 102, Troy, OH 45373
Dermatologists of Southwest Ohio, Inc.
6110 Radio Way, Mason, OH 45040

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: April 07, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

9 Total Publications

Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).
Journal: Pediatric dermatology
Published: September 25, 2025
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Office

3025 Governors Place Blvd, 
Dayton, OH 
 (24.0 miles away)
937-293-5567
Languages Spoken:
English
See accepted insurances

Martha Hickmann is a Dermatologist practicing medicine in Dayton, Ohio. Dr. Hickmann is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Kaposiform Hemangioendothelioma, Fetal Cystic Hygroma, Hemangioendothelioma, and Hemangioma.

Expertise in
26
conditions
Dr. Alan Fleischer
Dermatology
Expertise in
26
conditions
Dr. Alan Fleischer
Dermatology
Referral may be required

Hoxworth Center

3130 Highland Ave, 
Cincinnati, OH 
 (64.8 miles away)
513-584-3686
Languages Spoken:
English
See accepted insurances

Alan Fleischer is a Dermatologist practicing medicine in Cincinnati, Ohio. Dr. Fleischer is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Athlete's Foot, Ringworm, Actinic Keratosis, and Psoriasis.

Expertise in
16
conditions
Dr. Anne W. Lucky
Dermatology
Expertise in
16
conditions
Dr. Anne W. Lucky
Dermatology
Referral may be required

Dermatologists Of Southwest Ohio, Inc.

7691 5 Mile Road, Suite 312, 
Cincinnati, OH 
 (68.1 miles away)
513-232-3332
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anne Lucky is a Dermatologist practicing medicine in Cincinnati, Ohio. Dr. Lucky is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, and Dominant Dystrophic Epidermolysis Bullosa. Dr. Lucky is board certified in American Board Of Dermatology and American Board Of Pediatrics. Dr. Lucky is currently accepting new patients.

Frequently Asked Questions about Dr. Rocco T. Serrao

How do I make an appointment with Dr. Rocco T. Serrao?

You can book an appointment with Dr. Rocco T. Serrao by calling their office at 937-291-8814. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rocco T. Serrao a top-rated expert for Neurocutaneous Melanosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rocco T. Serrao is classified as an Distinguished expert for Neurocutaneous Melanosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rocco T. Serrao specialize in?

While Dr. Rocco T. Serrao is a Dermatology, they have specific expertise in Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Rocco T. Serrao participate in research or clinical trials?

Yes. Dr. Rocco T. Serrao has published 9 articles and abstracts on conditions like Neurocutaneous Melanosis. You can view a list of Dr. Rocco T. Serrao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rocco T. Serrao accept my insurance?

Dr. Rocco T. Serrao accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 937-291-8814 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Serrao's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile